Connect with us

Business

Cannabis Does a Better Job for Cancer Pain Than Opioids? – New Medical Study Changes Cancer Treatment Thinking

Published

on

Medical cannabis is safe and effective for treating lingering cancer pain in patients

Study Finds That Cannabis Is Safe For Treating Cancer Pain – Cancer Patients No Longer Need Opioids

As if being diagnosed with the Big C wasn’t bad enough, cancer patients often have to deal with a multitude of other debilitating conditions, with the worst being cancer-related pain.

While a cancer diagnosis doesn’t automatically mean you’ll be in pain, some 55% of cancer patients and 40% of survivors still suffer from chronic pain. Almost half of patients have to use opioids to manage the severe pain caused by the cancer itself which in most cases prevents patients as well as survivors from living a normal life. There are many factors that contribute to how much pain one feels; some days may be filled with pain while others are more tolerable, but no matter what, pain shouldn’t be accepted as part of cancer. There are treatments that are safe and effective available.

Unfortunately, opioid medications have become the standard treatment for severe pain, cancer or not. These ultra-strong chemical drugs may be effective at numbing pain, but at what cost? The opioid epidemic in America has taken millions of lives because it’s far too easy to overdose on it. Yet medical professionals continue to prescribe opioids to cancer patients and other terminally ill because it’s what helps them manage pain.

Opioids are extremely addictive, and even the slightest overdose can cause death.

So what are cancer patients struggling with pain left to do?

Cannabis is a Safe Alternative to Opioids

Medical marijuana has been making waves for its powerful ability to treat pain safely and naturally. This is critical for cancer patients.

brand-new assessment focusing on the therapeutic benefits of marijuana for pain caused by cancer confirms this. The study, which was published in the medical journal, Frontiers in Pain Research, was conducted by researchers in Israel. “Traditionally, cancer-related pain is mainly treated by opioid analgesics, but most oncologists perceive opioid treatment as hazardous, so alternative therapies are required,” says David Meiri, the study’s author, and an assistant professor at the Technion Israel Institute of Technology.

“Our study is the first to assess the possible benefits of medical cannabis for cancer-related pain in oncology patients; gathering information from the start of treatment and with repeated follow-ups for an extended period of time, to get a thorough analysis of its effectiveness,” he said.

For the assessment, they spoke with cancer patients who were seeking other choices available to treat their pain as well as other cancer symptom relief. They then worked with oncologists who issued a license for medical cannabis for their cancer patients, and interested patients who wanted to join the study were asked for their feedback.

“We encountered numerous cancer patients who asked us whether medical cannabis treatment can benefit their health,” explains Gil Bar-Sela, the study’s co-author, who is also an associate professor at the Ha’Emek Medical Center Afula.

The authors particularly wanted to get more information on cannabis for cancer-related pain. “Our review of existing research revealed that actually not much was known regarding its effectiveness, particularly for the treatment of cancer-related pain, and of what was known, most findings were inconclusive,” he adds.

“Patients completed anonymous questionnaires before starting treatment, and again at several time points during the following six months. We gathered data on a number of factors, including pain measures, analgesics consumption, cancer symptom burden, sexual problems, and side effects,” Bar-Sela adds.

After reviewing the data, the researchers found that a great deal of outcome measures revealed improvements. Cancer symptoms as well as pain scores were reduced though it was more significant that the patients were able to stop their intake of opioids or other painkillers. Additionally, they reported that almost half the participants were successfully able to wean off all painkillers just 6 months after treatment with medical marijuana.

“Medical cannabis has been suggested as a possible remedy for appetite loss, however, most patients in this study still lost weight. As a substantial portion were diagnosed with progressive cancer, a weight decline is expected with disease progression,” Meiri said.

Other Studies Reflect Similar Findings

In a 2021 clinical trial conducted by researchers at Minnesota’s Cancer Research Center together with the Minnesota Department of Health involved analyzing patients with stage IV cancer and their consumption of opioids and license cannabis products.

Thirty participants in the study were tasked to consume plant-derived extracts during the trial, starting at 2.5-5mg of THC/CBD, increasing to 30-40mg of THC and CBD each day for the course of the study which lasted two to four weeks. “Medical cannabis use led to improvements in achieving personalized pain goals and lower overall opioid requirements. No serious adverse events with cannabis were reported, and most patients who used cannabis reported that benefits outweighed negative effects.”

“Our results support prior studies suggesting cannabis may improve pain and minimize opioid utilization in both cancer and non-cancer settings… Incorporating cannabis into routine cancer care may improve pain control and minimize opioid requirements,” the authors concluded.

Meanwhile, a 2018 assessment from the European Journal of Internal Medicine, conducted by Tikun Olam researchers, looked at how effective cannabis was for cancer patients. They found that cannabis was efficient in decreasing cancer patients’ intake of opioids within 6 months from the time they started consuming it.

 Lihi Bar-lev Schleider, the study’s lead researcher, disclosed to the Rolling Stone that, “Cannabis is a very good alternative to reduce opioid consumption, to increase quality of life, and to reduce pain, nausea and vomiting.”

Conclusion

There is solid data out there about the efficacy of cannabis for treating cancer symptoms, including pain – which in itself is already very difficult to treat. If you or a loved one is taking opioid medications for cancer, speak to your oncologist about weaning off the drugs and switching to cannabis instead for a safer experience and improved quality of life.

Source: https://cannabis.net/blog/medical/cannabis-does-a-better-job-for-cancer-pain-than-opioids-new-medical-study-changes-cancer-treatm

Business

Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light

Published

on

By

Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).

The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.

India’s Indigenous LEO Satellite Vision

Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.

The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.

According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.

The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.

Regulatory Process Moves Forward

Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.

The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.

Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.

Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.

Broadband, Mobile Connectivity, and Strategic Applications

Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.

The company also intends to establish 20 to 22 ground stations across India to support network operations.

Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.

Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.

Major Step for India’s Space and Telecom Sectors

Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.

The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.

Continue Reading

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News